AI Science Tracker

Linköping University

2 discoveries from 2023 to 2026

Discoveries

Machine-learning mining uncovers hidden MXenes, including 11 new rare-earth MXenes

The journal abstract reports that machine-learning-assisted database mining identified 33 previously synthesized but unrecognized MXene candidates. Guided by that search, the researchers synthesized seven multilayer MXenes and realized 11 previously unexplored rare-earth-based MXenes. Experiments and modeling suggested semiconducting behavior and diverse magnetic states. Review is limited to the abstract and publication/affiliation metadata.

Technology: Machine-learning-assisted database mining for MXene candidates

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Seven multilayer MXenes were synthesized and 11 rare-earth MXenes realized; experiments and modeling assess electronic and magnetic behavior.
  • Still unknown: Review limited to the indexed abstract and publication metadata; full-paper methods and additional limitations were not assessed.
  • AI role: Machine learning performed database mining to screen candidate MXene compositions.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1126%2Fscience.aeh5957%22&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Machine-learning models identify cerebrospinal-fluid protein signatures for multiple-sclerosis activity and disability progression

Using Olink proteomics of 1,463 proteins in CSF and plasma from two prospective Swedish cohorts, the study trained prediction models for multiple-sclerosis diagnosis, 2-year disease activity and long-term disability worsening. Lower CSF neurofilament light (NfL) predicted absence of disease activity at two years (replication AUC 0.77). A stepwise model using 11 CSF proteins (CXCL13, LTA, FCN2, ICAM3, LY9, SLAMF7, TYMP, CHI3L1, FYB1, TNFRSF1B and NfL) predicted normalized age-related MS severity; subgroup classification AUCs in the replication cohort ranged from 0.88 to 0.90.

Technology: Stepwise logistic regression for diagnosis and disease activity; stepwise linear regression for long-term disability severity

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Using Olink proteomics of 1,463 proteins in CSF and plasma from two prospective Swedish cohorts, the study trained prediction models for multiple-sclerosis diagnosis, 2-year disease activity and long-term disability worsening.
  • Still unknown: The study included 143 people with early-stage MS and 43 healthy controls across discovery and replication cohorts; the replication MS cohort had 51 participants. The 2-year disease-activity comparison in replication was especially small (45 with activity versus 5 without). The 11-protein severity model predicted observational disability scores rather than treatment benefit. The plasma severity model had only 12 eligible replication samples and performed less convincingly. These are cohort-level results, not a clinically validated diagnostic assay or independent replication by another research group.
  • AI role: The study used statistical differential-expression testing to select disease-associated candidate proteins, then fitted logistic-regression models to predict MS diagnosis and 2-year disease activity and a linear-regression model to predict long-term normalized age-related MS severity. Stepwise feature selection produced the protein combinations; the frozen models were evaluated in a separate prospective cohort.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10616092/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 112 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.